Pharma & Biotech

Redcare Pharmacy finds itself navigating turbulent times as its chief financial officer unexpectedly resigns amid ongoing challenges. Jasper Eenhorst, who...

Danish pharmaceutical giant Novo Nordisk finds itself navigating turbulent market conditions as competing forces shape its trajectory. While the company...

Bayer's stock finds itself at a pivotal juncture as investors weigh operational improvements against the company's pharmaceutical pipeline potential. The...

Eli Lilly finds itself at a critical juncture, presenting investors with a complex narrative of ambitious expansion and unexpected research...

Bruker Corporation faces mounting pressure as market analysts maintain a cautious stance on the scientific instrument maker's shares. The prevailing...

As pharmaceutical companies compete to develop the next generation of breakthrough treatments, Incyte appears to be positioning a potentially significant...

Biopharmaceutical firm Denali Therapeutics finds itself navigating a turbulent period in the markets. Despite reporting significant progress in its clinical...

The curtain has fallen on Walgreens Boots Alliance's tenure as a publicly traded entity. Private equity firm Sycamore Partners has...

Replimune Group Inc. finds itself navigating turbulent market conditions as its stock value experiences a dramatic collapse. The biotechnology firm...

Investors in Liquidia Corporation are bracing for a pivotal moment as the biotechnology company prepares to unveil significant clinical trial...